Latest / The Vox Markets Podcast
2105: Q&A with Poolbeg Pharma CEO, Jeremy Skillington
Watch on YouTube
Following on from its £4.865 million raise last week, Poolbeg #POLB has announced that it has received FDA Orphan Drug Designation for POLB 001. Chief executive Jeremy Skillington joins us to tell us what it all means.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.